These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12032352)

  • 21. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
    Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
    Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
    Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
    Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S; Takagi H; Otani A; Suzuma K; Nishimura K; Honda Y
    Br J Pharmacol; 1999 May; 127(2):537-45. PubMed ID: 10385256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo.
    Mantell DJ; Owens PE; Bundred NJ; Mawer EB; Canfield AE
    Circ Res; 2000 Aug; 87(3):214-20. PubMed ID: 10926872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2.
    Wang J; Xu Y; Xu Y; Zhu H; Zhang R; Zhang G; Li S
    Cancer Invest; 2008 May; 26(4):359-68. PubMed ID: 18443956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M; Belleri M; Vacca A; Ribatti D
    Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
    Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
    J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells.
    Murata M; Kador PF; Sato S
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.
    Ortéga N; Jonca F; Vincent S; Favard C; Ruchoux MM; Plouët J
    Am J Pathol; 1997 Nov; 151(5):1215-24. PubMed ID: 9358746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.
    Wild R; Dhanabal M; Olson TA; Ramakrishnan S
    Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.
    Lobov IB; Brooks PC; Lang RA
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11205-10. PubMed ID: 12163646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
    Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
    Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation between the Ca(2+) signal and tube formation induced by vascular endothelial growth factor in bovine aortic endothelial cells.
    Kawasaki J; Hirano K; Hirano M; Nishimura J; Nakatsuka A; Fujishima M; Kanaide H
    Eur J Pharmacol; 2000 Jun; 398(1):19-29. PubMed ID: 10856444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis.
    Russell KS; Stern DF; Polverini PJ; Bender JR
    Am J Physiol; 1999 Dec; 277(6):H2205-11. PubMed ID: 10600838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.
    Hirata A; Ogawa S; Kometani T; Kuwano T; Naito S; Kuwano M; Ono M
    Cancer Res; 2002 May; 62(9):2554-60. PubMed ID: 11980649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis.
    Pedram A; Razandi M; Levin ER
    Endocrinology; 2001 Apr; 142(4):1578-86. PubMed ID: 11250939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.